What the Shatavari Libido Study Gets Right About Desire

Most conversations about low desire in young women begin with hormones. A new shatavari libido study begins somewhere else: exhaustion. The eight-week trial gave a standardized shatavari root extract to women in their reproductive years and measured what happened to their sexual function scores, their sleep, and their fatigue.

The shatavari libido study was randomized, double-blind, and placebo-controlled, and it ran for 56 days. Seventy healthy women reporting low libido were assigned to take 300 mg of the extract per day or a matching placebo. The published paper describes the participants as aged 18 to 45, while the company release puts the range at eighteen to forty-two.

Results were published in the Journal of Medicine and Life. The primary endpoint was the total Female Sexual Function Index score, a validated questionnaire covering desire, arousal, lubrication, orgasm, satisfaction, and pain. That score climbed 67.96% from baseline in the extract group, compared with 7.58% in the placebo group. The between-group difference on the final day was 3.3 points, with a 95% confidence interval of 1.6 to 5.0, and lubrication showed the largest domain-level gain.

Secondary measures in the shatavari libido study told a similar story. Scores on the Female Sexual Encounter Profile-Revised rose 61.9% in the extract group against 4.44% for placebo, and anxiety and depression scores on the Hospital Anxiety and Depression Scale fell 24.81%. The extract was well tolerated, with no serious adverse events reported over the study period, according to Nutritional Outlook.

Waleria HealthTech, the company behind the extract, released additional detail from the trial, as reported by Nutraceuticals World. Objectively measured vaginal moisture improved 63%, sexual desire rose 34.54%, arousal rose 64%, and satisfaction rose 80%. Fatigue improved 60.1% and sleep disturbance improved 21.8%.

The exhaustion angle behind the trial design

Komal Baldwa, founder of Waleria HealthTech, said in comments reported by Nutritional Outlook that the study was built around a specific observation. "The same symptom does not mean the same root cause," she said. A woman in her early twenties and a woman in her fifties can both report low desire, but they experience it in different physiological and life-stage contexts. This trial focused on younger women with intact ovarian function whose fatigue and disrupted sleep may be dragging desire down.

That framing lines up with how clinicians are told to think about female sexual dysfunction. The condition is multifactorial, shaped by biology, psychology, relationships, medication, and context, and the American College of Obstetricians and Gynecologists recommends a comprehensive evaluation rather than treating libido as an isolated number, as Nutritional Outlook reported.

Nutritional Outlook also cited a systematic review of reproductive-age women that found a high prevalence of sexual dysfunction with many possible predictors, which is why low desire resists a single-cause explanation. The shatavari libido study did not set out to prove that fatigue or poor sleep causes low desire. It only showed that an intervention tracking whole-body measures moved several scores at once.

What to keep in perspective

The shatavari libido study has real limits. It was small, it ran at a single site, and it lasted eight weeks. It enrolled healthy women with low-libido characteristics, so the findings do not automatically extend to women with diagnosed sexual dysfunction, significant medical conditions, or medication-related symptoms.

The results also belong to one defined extract, not to shatavari in general. The company's release describes a standardized full-spectrum preparation with specified phytochemicals, and the researchers caution that results from one extract should not be generalized to every shatavari powder on a store shelf. That distinction matters whenever a single shatavari libido study gets shared online as proof the herb works for everyone.

For now, the shatavari libido study adds one data point to a thin evidence base: a small, short, well-controlled trial in which a defined shatavari extract improved validated sexual function scores and eased fatigue and sleep complaints in younger women. Anyone curious should treat it like any supplement claim and bring it to a clinician first, since standard care starts with a full evaluation of symptoms and medications. It also helps to keep the wider sexual-health picture in view: GenZNewZ recently covered the STI morning-after pill and the catch that comes with doxy-PEP, and a reproductive health report on what Gen Z women are actually dealing with.